An enzyme-linked immunosorbent assay for the determination of immunity to measles virus was developed and standardized; it was compared to the hemagglutination inhibition and plaque reduction neutralization methods for sensitivity and specificity. The conditions of the enzyme-linked immunosorbent assay were adjusted such that groups of susceptible and immune individuals were clearly separable on the basis of the reactivity of a single (1:100) dilution of their sera to viral and control antigens. The range of values corresponding to susceptibility and immunity was defined by using the distribution of values observed from testing sera obtained from susceptible and immune control groups. The enzyme-linked immunosorbent assay was then applied in a study of measles vaccinees and found to be more sensitive than the hemagglutination inhibition method and equal in sensitivity to the plaque reduction neutralization method. The three methods were equal in specificity. Thus, the measles virus enzyme-linked immunosorbent assay is a rapid, reproducible, sensitive, and specific method for screening for Cells and virus. Vero cells (obtained from Paul Albrecht) were grown at 37°C in Eagle minimal essential medium supplemented with 100 U of penicillin per ml, 100 ,ug of streptomycin per ml, and 2 mM L-glutamine (MEM) containing 10% fetal bovine serum (FBS) (10% MEM). A 75-cm2 monolayer of Vero cells was infected with the Edmonston strain of measles virus (obtained from Paul Albrecht). In 2 days when approximately one-half of the monolayer showed a cytopathic effect, the cells were scraped into 10 ml of 10% MEM, and 2.5-ml volumes were sonicated for 30 s. This virus stock was plaque titrated, diluted, and stored at -70°C in small volumes.
Although many tests are available for detecting measles antibody, an accurate method for determining immune status is sorely needed. The hemagglutination inhibition test (HI) is the most commonly used method of measuring measles antibody. This test is a less than ideal method for evaluating immunity against measles virus in that it is cumbersome to perform and subject to considerable variation (12). It is also less sensitive than the plaque reduction neutralization test (PRN) (1) . A test for immune status that is easily performed, specific, and sensitive would be particularly useful in supporting the measles eradication program (6) to resolve the controversies regarding measles vaccine failure (3a, 5) or in supporting proposed changes in recommendations (M. D. Murphy, P. A. Brunell, A. W. Lievens, and E. Cobb, in press).
In this study, we used serum banks from groups of individuals with known immune status to standardize the enzyme-linked immunosorbent assay (ELISA) for determination of susceptibility. The measles virus ELISA was evaluated for its ability to separate immune individuals from susceptible individuals and was compared with the HI and PRN methods. When applied to a group of vaccinees, ELISA was as specific as, yet more sensitive than, HI.
MATERIALS AND METHODS
Human sera. Blood was obtained from 19 adults who were born before 1954 and who worked in a pediatric outpatient department. Sera from these adults served as the immune controls as the adults were born well before the introduction of measles vaccine and had undoubtedly been exposed to measles virus both during childhood and as a result of their occupations. For Three days later when a cytopathogenic effect was observed in 75% of the monolayer cells, the medium (M1) was collected for antigen production and replaced with fresh MEM. Four days after infection when the entire monolayer showed a cytopathogenic effect, the cells of both the virusinfected flask and a mock-infected control flask were scraped into the medium, and then the medium was cleared of cells by sedimentation at 500 x g for 20 min. Equal dilutions of this medium (M2) and Ml were compared in ELISA with known positive anti-measles virus sera; M2 was found to bind a greater amount of antibody. Therefore, M2 culture fluids were selected as the source of viral and control antigens. M2 culture fluids were then centrifuged at 78,000 x g for 2 h. The viral and control antigen pellets each were resuspended in 2 ml of 0.01 M phosphate buffer (pH 7.4) in saline (PBS). A subsequent sonication and low-speed centrifugation further clarified the antigens. Then the control antigen was adjusted to a protein concentration equal to that of the viral antigen (9) . The optimum dilution of the viral antigen was determined by checkerboard titrations with the enzyme conjugate. Antigens were stored frozen at -70°C.
ELISA. ELISA was performed in polyvinyl microtiter plates (Costar, Cambridge, Mass.) with the following modifications of the method of Voller and Bidwell (11) . Duplicate wells were coated with 0.1 ml of measles or control antigen in carbonate buffer for at least 18 h at 4°C. The fluid was removed, and wells were rinsed three times with PBS containing 0.05% Tween 20 (PBS-T). Serum diluted 1:100 in PBS-T containing 1% fetal calf serum and 10% globulindepleted goat serum to decrease nonspecific reactivity (Z. Shehab, manuscript in preparation) was added to two wells containing control antigen and two wells containing measles antigen. After incubation at 37°C for 1 h and three PBS-T washes, 0.1 ml of a 1:1,500 dilution of goat anti-human immunoglobulin G (Antibodies, Inc., Davis, Cal.) conjugated to alkaline phosphatase (Sigma Chemical Co., St. Louis, Mo.) (kindly prepared by Ziad Shehab) was added to each well. After a 1-h incubation at 37°C, the plates were washed three times in PBS-T. Then 0.1 ml of the substrate (1 mg of pnitrophenol phosphate per ml of diethanolamine buffer) was added to each well, and the plates were incubated at room temperature for 45 min. The enzyme reaction was stopped with 0.025 ml of 3 N NaOH. The optical density (OD) 102 PFU of measles virus, and incubated at 37°C for 1 h. Medium was removed from the culture wells, and 0.1 ml of the virusserum mixture was adsorbed onto the monolayers for 1 h at 370C. This mixture was then replaced with MEM containing 5% FBS and 1% (wt/vol) agarose (5% MEM-A; Sea Kem, FMC Corp., Rockland, Maine). Each dilution of sera was tested in triplicate. Four days later, 0.5 ml of 5% MEM-A containing 1:20,000 (wt/vol) of neutral red was layered onto each well. In 48 h, plaques became visible and were counted through the agarose. Reduction of 50% of the plaques by sera was calculated by using Karber's formula. Sera with titers of less than 1:8 are referred to subsequently as negative for PRN antibody.
RESULTS
Standardization of measles virus ELISA. The optimal concentrations of antigen, serum, and enzyme conjugate were determined by cross titrations, using the sera from known susceptible children to evFluate specificity and from immune adult controls to evaluate sensitivity. Dilutions were chosen which maximized the AOD values of the immune serum controls without increasing the AOD values of the susceptible controls. These standardization titrations thereby ensured that the susceptible population was clearly separable from the immune population on the basis of the AOD value of a single dilution of serum. The length of incubation of the enzymatic reaction (45 min) was chosen to maximize the difference between rpactivity to viral antigen and that to control antigen (Fig. 1) . The 45-min time period was also at the plateau phase of the enzyme reaction, thus minimizing the effect of minor variations in reaction time on the AOD value.
The mean AOD value for the 49 susceptible children was 0.016 ± 0.016. All AOD values that were three standard deviations above this mean, that is above 0.062 limits, were considered seropositive (Fig. 2) as measured by HI. This measles virus ELISA, which used a single serum dilution, is an extremely rapid and simple method requiring a very small volume of serum and easily stored reagents. It is therefore ideal for screening large numbers of samples to assess vaccine efficacy or for epidemiological investigations.
The measles virus ELISA was more sensitive than the measles virus HI in the testing of relatively low-titered serum. In prior studies, ELISA was not observed to be more accurate than HI for the diagnosis of clinical measles (2, 4, 7, 8) . After a primary measles virus infection, measles antibody rises to a high level easily detected by HI. It is only in the on November 6, 2017 by guest http://jcm.asm.org/ testing for low levels of antibody that the lack of sensitivity of HI is apparent. A recent study of a commercially available measles virus ELISA (3) found a small number of discrepancies in HI and ELISA methods and indicated that the measles virus ELISA may be more sensitive than HI. By the use of standard groups of sera and PRN, we determined that the differences between the results of ELISA and HI were due to the greater sensitivity of ELISA. In fact, the measles virus ELISA appears equivalent to the very time-consuming, but very sensitive, PRN.
The measles virus ELISA described in this communication should facilitate studies of large numbers of sera to determine measles virus immune status. It is particularly useful for the detection of low levels of antibody found long after natural infection or immunization.
